Paula Cahuina-Lope
Biographic Data
| ID | 7984270 |
|---|---|
| NAME | Paula Cahuina-Lope |
| GIVEN NAMES | Paula |
| FAMILY NAME | Cahuina-Lope |
| SIGNATURE | CAHUINA-LOPE P |
| AFFILIATIONS | Instituto Nacional de Salud |
| ORCID | 0000-0002-1259-557X |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 2 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2020 |
| LATEST PUBLICATION YEAR | 2021 |
| H-INDEX | 0 |
La regulación de los ensayos clínicos para la Covid-19 en el Perú
COVID-19 has affected the conduct of clinical trials worldwide. Once the health emergency began in Peru, the national government took measures to guarantee the conduct of COVID-19 clinical trials. A national research ethics committee was exclusively established for COVID-19 clinical trials; and a regulatory framework was implemented to ensure the ethical and timely conduct of these studies. To december 31, 2020, the Peruvian National Health Insti…
Características de los ensayos clínicos oncológicos presentados al Instituto Nacional de Salud del Perú, 1995-2019
A descriptive observational study was carried out to identify the characteristics of the oncological clinical trials submitted to the Instituto Nacional de Salud del Perú during the period from 1995 to 2019. The information was obtained from the Peruvian Registry of Clinical Trials. We identified 1,996 clinical trials during the studied period, from which 470 were oncological (23.5%); 74.9% of the oncological clinical trials were mainly sponsored…
No prominent works on this page.
Características de los ensayos clínicos oncológicos presentados al Instituto Nacional de Salud del Perú, 1995-2019
A descriptive observational study was carried out to identify the characteristics of the oncological clinical trials submitted to the Instituto Nacional de Salud del Perú during the period from 1995 to 2019. The information was obtained from the Peruvian Registry of Clinical Trials. We identified 1,996 clinical trials during the studied period, from which 470 were oncological (23.5%); 74.9% of the oncological clinical trials were mainly sponsored…
La regulación de los ensayos clínicos para la Covid-19 en el Perú
COVID-19 has affected the conduct of clinical trials worldwide. Once the health emergency began in Peru, the national government took measures to guarantee the conduct of COVID-19 clinical trials. A national research ethics committee was exclusively established for COVID-19 clinical trials; and a regulatory framework was implemented to ensure the ethical and timely conduct of these studies. To december 31, 2020, the Peruvian National Health Insti…
Humanities (2 works) · Medicine (2 works) · Philosophy (2 works) · Philosophy (2 works) · Coronavirus disease 2019 (COVID-19 (1 works) · Ethics and bioethics in healthcare (1 works) · Ethics in Clinical Research (1 works) · Health and Medical Research Impacts (1 works) · Political science (1 works) · Public Health and Environmental Issues (1 works)